Connect
MJA
MJA

Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia

Satvinder S Dhaliwal and Timothy A Welborn
Med J Aust 2017; 206 (1): 51. || doi: 10.5694/mja16.00599
Published online: 16 January 2017

In a recent issue of the MJA, Banks and colleagues1 reported that one-fifth of the Australian population aged 45–74 years have a high absolute risk of a cardiovascular disease (CVD) event over 5 years, and they conclude by recommending an escalation of drug therapy to lower blood pressure and lipid levels. This view was supported by Chow and Rodgers2 in their accompanying editorial.

  • Satvinder S Dhaliwal1
  • Timothy A Welborn2

  • 1 Curtin University, Perth, WA
  • 2 Sir Charles Gairdner Hospital, Perth, WA

Correspondence: s.dhaliwal@curtin.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.